The successful achievement of pregnancies following
pre-implantation genetic diagnosis (PGD) was first reported in
April 1990. The technology is often used for patients who are at
substantial risk of conceiving a pregnancy affected by a known
genetic disorder, however from this technology other more
controversial uses have arisen such as HLA typing to save the life
of a sibling, gender selection for social reasons, the prevention
of late onset diseases, or the prevention of diseases which may be
genetically predisposed to developing such as breast cancer. The
technology surrounding PGD is constantly developing, giving rise to
new and unexpected consequences that create fresh ethical and legal
dilemmas.
Featuring internationally recognized experts in the field, this
book critically explores the regulation of PGD and the broader
legal and ethical issues associated with it. It looks at the
regulatory situation in a number of jurisdictions including New
Zealand, Australia and the United Kingdom, but it also explores a
number of themes of wide significance including a historical
consideration of PGD and its part in the creation of the "genetic
embryo" as a political tool, the over regulation of PGD and the
ethical difficulties in handling additional unexpected medical
information yielded by new technologies. This book will be of
particular interest to academics and students of law, medicine and
ethics.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!